PREDICS Study: PCT Reveals Early Dehiscence in Colorectal Surgery
PREDICS
PREDICS Study: Procalcitonin Reveals Early Dehiscence in Colorectal Surgery
1 other identifier
observational
504
1 country
1
Brief Summary
Procalcitonin (PCT) is a biomarker used to monitor serious bacterial infections and guide antibiotic therapy. Anastomotic leak (AL) after colorectal surgery is a severe complication associated with relevant short and long-term sequelae. The aim of our study is to assess the predictive value of PCT level for early diagnosis of anastomotic leak after colorectal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 20, 2013
CompletedFirst Posted
Study publicly available on registry
March 25, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedSeptember 29, 2014
September 1, 2014
1.8 years
March 20, 2013
September 26, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anastomotic leak
within the first 30 days after he operation
Secondary Outcomes (1)
Intra-abdominal infection
within 30 days from the operation
Study Arms (1)
PCT
Patients undergoing colorectal surgery with an anastomosis performed
Interventions
Eligibility Criteria
Patients undergoing all different kinds of colorectal surgery (from right colectomies to low anterior resection), in elective setting, either for cancer or benign disease (ex diverticular disease) with an anastomosis being performed (ileo-colic, colo-colic, or colo-rectal)
You may qualify if:
- all patients undergoing all different kinds of colorectal surgery(from right colectomies to low anterior resection) in our institution, in elective setting, either for cancer or benign disease (ex diverticular disease) with an anastomosis being performed (ileo-colic, colo-colic, or colo-rectal
You may not qualify if:
- age \< 18 years,
- pregnant women,
- patients undergoing abdomino-perineal resection or other kinds of colorectal-surgery without an anastomosis being performed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sant'Andrea University Hospital
Rome, 00189, Italy
Related Publications (1)
Giaccaglia V, Salvi PF, Antonelli MS, Nigri G, Pirozzi F, Casagranda B, Giacca M, Corcione F, de Manzini N, Balducci G, Ramacciato G. Procalcitonin Reveals Early Dehiscence in Colorectal Surgery: The PREDICS Study. Ann Surg. 2016 May;263(5):967-72. doi: 10.1097/SLA.0000000000001365.
PMID: 26528879DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 20, 2013
First Posted
March 25, 2013
Study Start
December 1, 2012
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
September 29, 2014
Record last verified: 2014-09